Centocor, a pharmaceutical company, issued two press releases on June 11, touting the positive results of its new TNF-inhibitor drug golimumab in three separate Phase III clinical trials. The results of the trials may help Centocor and Schering-Plough (working together to develop and market the drug) to move closer to receiving FDA approval for the drug for the treatment of Rheumatoid Arthritis, psoriatic arthritis and ankylosing spondylitis.
Centocor claims that all three studies show...
Earlier in November, the American College of Rheumatology held its 71st annual scientific meeting. Among the many research studies... Read more »
Tumor necrosis factor inhibitors such as etanercept (Enbrel) or infliximab (Remicade) are some of the newest and most expensive drugs... Read more »
New research published online in June in the journal "Nature Medicine" finds that the TNF inhibitor etanercept... Read more »
The recent meeting of the European League Against Rheumatism (EULAR) continued to present more data on the tumor necrosis factor (TNF)... Read more »
After writing the other week about the depressing research related to mortality rates of RA sufferers and the link to cardiovascular... Read more »
Rheumatoid and psoriatic arthritis are among the most disabling forms of arthritis. Rheumatoid arthritis (RA), which affects 1 percent of the U.S.... Read more »
Source: ADAM Encyclopedia
Arthritis - psoriatic Treatment Your doctor may prescribe nonsteroidal anti-inflammatory drugs (NSAIDS) to reduce pain and inflammation... Read more »
According to the drug golimumab shows promise in treating psoriatic arthritis, a condition that affects about 11 percent of people with the skin... Read more »
The U.S. Food and Drug Administration (FDA) has approved a new drug for people who suffer from arthritis related to immune-system disorders. The... Read more »
According to a new study, recently diagnosed rheumatoid arthritis patients who do respond to methotrexate respond well to TNF blocker drugs such as... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
